Onderneming Acura Pharmaceuticals, Inc. Other OTC
Aandelen
ACUR
US00509L8028
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07-04-08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01-02-98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01-03-98 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 01-02-09 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01-02-98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01-03-98 |
William Skelly
BRD | Director/Board Member | 73 | 01-05-96 |
Director/Board Member | 53 | 01-12-02 | |
George Ross
BRD | Director/Board Member | 82 | 01-01-08 |
Robert Jones
CEO | Chief Executive Officer | 65 | 07-04-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 66 001 783 | 10 081 080 ( 15,27 %) | 0 | 15,27 % |
Bedrijfsgegevens
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |